• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡嗪酰胺诱发的肉芽肿性肝炎。

Pyrazinamide-induced granulomatous hepatitis.

作者信息

Knobel B, Buyanowsky G, Dan M, Zaidel L

机构信息

Department of Medicine B, Edith Wolfson Medical Center, Holon, Israel.

出版信息

J Clin Gastroenterol. 1997 Jun;24(4):264-6. doi: 10.1097/00004836-199706000-00019.

DOI:10.1097/00004836-199706000-00019
PMID:9252856
Abstract

Noncaseating granulomatous hepatitis may be caused by a variety of drugs, but we have not found, by computer search of the literature, a previous describe of granulomatous hepatitis associated with pyrazinamide. We describe a 52-year-old man with hectic fever, chills, extreme fatigue, liver damage, and hyperuricemia about 4 weeks after commencing pyrazinamide therapy. A liver biopsy specimen showed noncaseating epithelioid granulomas. The patient recovered soon after the interruption of tuberculostatic treatment.

摘要

非干酪样肉芽肿性肝炎可能由多种药物引起,但通过计算机检索文献,我们未发现之前有关于吡嗪酰胺相关肉芽肿性肝炎的描述。我们描述了一名52岁男性,在开始吡嗪酰胺治疗约4周后出现弛张热、寒战、极度疲劳、肝损伤和高尿酸血症。肝脏活检标本显示非干酪样上皮样肉芽肿。停用抗结核治疗后,患者很快康复。

相似文献

1
Pyrazinamide-induced granulomatous hepatitis.吡嗪酰胺诱发的肉芽肿性肝炎。
J Clin Gastroenterol. 1997 Jun;24(4):264-6. doi: 10.1097/00004836-199706000-00019.
2
Antituberculosis agents.抗结核药物
Med Clin North Am. 1988 May;72(3):661-8. doi: 10.1016/s0025-7125(16)30764-7.
3
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].抗结核治疗过程中的暴发性肝炎(附2例报告)
Dakar Med. 1995;40(2):129-31.
4
[Isoniazid-induced hepatic failure. Report of a case].
Arq Gastroenterol. 2000 Jan-Mar;37(1):72-5. doi: 10.1590/s0004-28032000000100014.
5
Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.尼泊尔西部一家三级护理教学医院中结核病患者所经历的药物不良反应模式。
Pak J Pharm Sci. 2008 Jan;21(1):51-6.
6
[Liver injury under tuberculostatic treatment].
Praxis (Bern 1994). 1997 Apr 9;86(15):626-9.
7
Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide.
Tubercle. 1986 Jun;67(2):99-108. doi: 10.1016/0041-3879(86)90003-6.
8
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.采用含利福平、异烟肼和吡嗪酰胺方案治疗的高龄老年肺结核患者的临床结局。
Clin Interv Aging. 2016 Mar 11;11:299-306. doi: 10.2147/CIA.S95411. eCollection 2016.
9
Pyrazinamide-induced sideroblastic anemia.吡嗪酰胺诱发的铁粒幼细胞性贫血。
Am J Hematol. 2012 Mar;87(3):305. doi: 10.1002/ajh.22125. Epub 2011 Aug 4.
10
Repeat exposure to active tuberculosis and risk of re-infection.再次接触活动性肺结核与再感染风险
Med J Aust. 2016 Feb 1;204(2):77-8. doi: 10.5694/mja15.00749.

引用本文的文献

1
Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a H NMR based metabolomics approach.基于核磁共振氢谱代谢组学方法揭示的吡嗪酰胺诱导的大鼠肝毒性及性别差异
Toxicol Res (Camb). 2016 Oct 5;6(1):17-29. doi: 10.1039/c6tx00245e. eCollection 2017 Jan 1.
2
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.抗结核药物相关肝毒性:机制与管理
J Clin Exp Hepatol. 2013 Mar;3(1):37-49. doi: 10.1016/j.jceh.2012.12.001. Epub 2012 Dec 20.
3
Hepatotoxic effects of therapies for tuberculosis.
结核病治疗的肝毒性作用。
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):543-56. doi: 10.1038/nrgastro.2010.134. Epub 2010 Aug 31.
4
Hepatotoxicity of antibacterials: Pathomechanisms and clinical.抗菌药物的肝毒性:发病机制与临床。
Infection. 2010 Feb;38(1):3-11. doi: 10.1007/s15010-009-9179-z. Epub 2010 Jan 27.
5
Drug-induced liver injury: is it somehow foreseeable?药物性肝损伤:在某种程度上可以预见吗?
World J Gastroenterol. 2009 Jun 21;15(23):2817-33. doi: 10.3748/wjg.15.2817.